IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes

Diabetologia

Volumn 47, Issue 11, 2004, Pages 1984-1989

  Hillman, M ^a   Torn C ^a   Thorgeirsson, H ^a   Landin Olsson, M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes mellitus; GAD65 enzyme; Immunoglobulin G; Radioimmunoprecipitation assay

Indexed keywords

C PEPTIDE; CYTOKINE; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INSULIN; SEPHAROSE; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE FREQUENCY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOPRECIPITATION; SAMPLE SIZE; TH1 CELL; TH2 CELL; ADOLESCENT; BLOOD; CLASSIFICATION; ENZYMOLOGY; IMMUNOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED;

EID: 12144278432     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1558-5     Document Type: Article

References (29)

1. Törn C, Landin-Olsson M, Östman J et al. (2000) Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds. Diabetes Metab Res Rev 16:442-447
2. Carlsson A, Sundkvist G, Groop L, Tuomi T (2000) Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 85:76-80
3. Törn C, Gupta M, Nikitina Zake L, Sanjeevi CB, Landin-Olsson M (2003) Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum Immunol 64:902-909
4. Tuomi T, Carlsson A, Li H et al. (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157
5. Hagopian WA, Sanjeevi CB, Kockum I et al. (1995) Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511
6. Turner R, Stratton I, Horton V et al. (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288-1293
7. Bonifacio E, Scirpoli M, Kredel K, Fuchtenbusch M, Ziegler AG (1999) Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol 163:525-532
8. Couper JJ, Harrison LC, Aldis JJ, Colman PG, Honeyman MC, Ferrante A (1998) IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes. Hum Immunol 59:493-499
9. Schmid S, Molteni A, Fuchtenbusch M, Naserke HE, Ziegler AG, Bonifacio E (2002) Reduced IL-4 associated antibody responses to vaccine in early pre-diabetes. Diabetologia 45:677-685
10. Hawa MI, Fava D, Medici F et al. (2000) Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care 23:228-233
11. Koczwara K, Schenker M, Schmid S, Kredel K, Ziegler AG, Bonifacio, E (2003) Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse. Clin Immunol 106:155-162
12. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17: 138-146
13. Petersen JS, Kulmala P, Clausen JT, Knip M, Dyrberg T (1999) Progression to Type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65). Childhood Diabetes in Finland Study Group. Clin Immunol 90:276-281
14. Romagnani S (1996) Th1 and Th2 in human diseases. Clin Immunol Immunopathol 80:225-235
15. Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
16. Verge CF, Stenger D, Bonifacio E et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in Type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
17. Törn C, Landin-Olsson M, Scherstén B (2001) Predictability of C-peptide for autoimmune diabetes in young adult diabetic patients. Pract Diab Int 18:83-88
18. Seissler J, Eikamp K, Schott M, Scherbaum WA (2002) IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from Type 1 diabetes. Horm Metab Res 34:186-191
19. Ng WY, Lui KF, Cheah JS, Thai AC (2002) IgG1 subclass dominates autoimmune response to tyrosine phosphatase-like molecule IA-2 in Chinese Type 1 diabetes patients. Horm Metab Res 34:596-600
20. Kero J, Gissler M, Hemminki E, Isolauri E (2001) Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, Type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol 108:781-783
21. Ng WY, Thai AC, Lui KF, Yeo PP, Cheah JS (1999) Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients. Diabetes Res Clin Pract 43:127-135
22. Kasuga A, Shimada A, Ozawa Y, Mamyama T, Oya K, Saruta T (2000) IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among Type 1 diabetes in Japanese. Endocr J 47:57-62
23. Rook G (2001) Th1- or Th2-cell commitment during infectious disease: an oversimplification? Trends Immunol 22:481-482
24. Sheikh A, Smeeth L, Hubbard R (2003) There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: Lack of support for the hygiene hypothesis. J Allergy Clin Immunol 111:131-135
25. Feili-Hariri M, Falkner DH, Gambotto A et al. (2003) Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis. Hum Gene Ther 14:13-23
26. Yang Z, Chen M, Wu R et al. (2002) Suppression of autoimmune diabetes by viral IL-10 gene transfer. J Immunol 168:6479-6485
27. Cameron MJ, Arreaza GA, Zucker P et al. (1997) IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 159:4686-4692
28. Kukreja A, Maclaren NK (2000) Current cases in which epitope mimicry is considered as a component cause of autoimmune disease: immune-mediated (type 1) diabetes. Cell Mol Life Sci 57:534-541
29. Petrovsky N, Silva D, Schatz D (2003) Vaccine therapies for the prevention of Type 1 diabetes mellitus. Paediatr Drugs 5:575-582